Reduced absorption of lipophilic anti-epileptic medications when used concomitantly with the anti-obesity drug orlistat

被引：7

作者：

Bigham, Sarah ^{[1
]}

McGuigan, Christopher

MacDonald, Bridget K.

机构：

[1] St George Hosp, SHO Neurol, London, England

[2] St George Hosp, SPR Neurol, London, England

来源：

EPILEPSIA | 2006年 / 47卷 / 12期

关键词：

D O I：

10.1111/j.1528-1167.2006.00945_1.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2207 / 2207

页数：1

共 5 条

[1] Drug interaction in a renal transplant patient: cyclosporin-neoral and Orlistat [J].

Evans, S ;

Michael, R ;

Wells, H ;

MacLean, D ;

Gordon, I ;

Taylor, J ;

Goldsmith, D .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (02) :493-496

[2] Bodyweight gain and anticonvulsants - A comparative review [J].

Jallon, P ;

Picard, F .

DRUG SAFETY, 2001, 24 (13) :969-978

[3] Orlistat enhances warfarin effect [J].

MacWalter, RS ;

Fraser, HW ;

Armstrong, KM .

ANNALS OF PHARMACOTHERAPY, 2003, 37 (04) :510-512

[4] The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers [J].

Melia, AT ;

Mulligan, TE ;

Zhi, JG .

JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (07) :654-658

[5] Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers [J].

Weber, C ;

Tam, YK ;

SchmidtkeSchrezenmeier, G ;

Jonkmann, JHG ;

vanBrummelen, P .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (01) :87-90

← 1 →